Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
Anna Goc, Aleksandra Niedzwiecki, Vadim Ivanov, Svetlana Ivanova, Matthias Rath
doi:10.1556/1886.2021.00022
Despite vaccine availability, the global spread of COVID-19 continues, largely facilitated by emerging SARS-CoV-2 mutations. Our earlier research documented that a specific combination of plant-derived compounds can inhibit SARS-CoV-2 binding to its ACE2 receptor and controlling key cellular mechanisms of viral infectivity. In this study, we evaluated the efficacy of a defined mixture of plant extracts and micronutrients against original SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. The composition containing vitamin C, N-acetylcysteine, resveratrol, theaflavin, curcumin, quercetin, naringenin, baicalin, and broccoli extract demonstrated a highest efficacy by inhibiting the receptor-binding domain (RBD) binding of SARS-CoV-2 to its cellular ACE2 receptor by 90%. In vitro exposure of test pseudo-typed variants to this formula for 1 h before or simultaneously administrated to human pulmonary cells resulted in up to 60% inhibition in their cellular entry. Additionally, this composition significantly inhibited other cellular mechanisms of viral infectivity, including the activity of viral RdRp, furin, and cathepsin L. These findings demonstrate the efficacy of natural compounds against SARS-CoV-2 including its mutated forms through pleiotropic mechanisms. Our results imply that simultaneous inhibition of multiple mechanisms of viral infection of host cells could be an effective strategy to prevent SARS-CoV-2 infection.
References
Andreano, Piccini, Licastro, Casalino, Johnson et al., SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma, Proc Natl Acad Sci,
doi:10.1073/pnas.2103154118Barbour, Rayya, Houssam, El-Hakim, Niedzwiecki et al., Alleviation of histopathologic effects of avian influenza virus by a specific nutrient synergy, Int J Appl Res Vet Med
Collier, Marco, Ferreira, Meng, Datir et al., Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccineelicited antibodies, Nature,
doi:10.1038/s41586-021-03412-7Deryabin, Lvov, Botikov, Ivanov, Kalinovsky et al., Effects of a nutrient mixture on infectious properties of the highly pathogenic strain of avian influenza virus A/H5N1, Biofactors,
doi:10.1002/biof.5520330201Du, He, Zhou, Liu, Zheng et al., The spike protein of SARS-CoV-a target for vaccine and therapeutic development, Nat Rev Microbiol,
doi:10.1038/nrmicro2090Dyson, Hill, Moore, Curran-Sebastian, Tildesley et al., Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics, Nat Commun,
doi:10.1038/s41467-021-25915-7Follis, York, Nunberg, Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry, Virology,
doi:10.1016/j.virol.2006.02.003Glowacka, Bertram, Müller, Allen, Soilleux et al., Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol
Goc, Ivanov, Ivanova, Chatterjee, Rath et al., Simultaneous inhibition of SARS-CoV-2 infectivity by a specific combination of plant-derived compounds, Eur J Bio Biotech,
doi:10.24018/ejbio.2021.2.5.258Goc, Niedzwiecki, Rath, Polyunsaturated u-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry, Sci Rep,
doi:10.1038/s41598-021-84850-1Goc, Sumera, Rath, Niedzwiecki, Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions, PLOS ONE,
doi:10.1371/journal.pone.0253489Gopinath, Jokinen, Kurkinen, Pentikäinen, Screening of natural products targeting SARS-CoV-2-ACE2 receptor interface -A MixMD based HTVS pipeline, Front Chem,
doi:10.3389/fchem.2020.589769Ivanov, Goc, Ivanova, Niedzwiecki, Rath, Inhibition of ACE2 expression by Ascorbic acid alone and its combination with other natural compounds, Infect Dis Res Trmt (Auckl),
doi:10.1177/1178633721994605Ivanov, Ivanova, Niedzwiecki, Rath, Effective and safe global public health strategy to fight the COVID-19 pandemic: specific micronutrient combination inhibits Coronavirus cell-entry receptor (ACE2) expression, J Cell Med Nat Health
Jariwalla, Gangapurkar, Pandit, Kalinovsky, Niedzwiecki et al., Micronutrient cooperation in suppression of HIV production in chronically and latently infected cells, Mol Med Rep,
doi:10.3892/mmr_00000268Jariwalla, Roomi, Gangapurkar, Kalinovsky, Niedzwiecki et al., Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids, Biofactors,
doi:10.1002/biof.5520310101Ming, Qiang, Involvement of spike protein, furin, and ACE2 in SARS-CoV-2-related cardiovascular complications, SN Compr Clin Med,
doi:10.1007/s42399-020-00400-2Muchtaridi, Fauzi, Ikram, Gazzali, Wahab, Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2, Molecules,
doi:10.3390/molecules25173980Simmons, Gosalia, Rennekamp, Reeves, Diamond et al., Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci
Tian, Huang, Fang, Wu, Furin DB: A database of 20-residue furin cleavage site motifs, substrates and their associated drugs, Int J Mol Sci,
doi:10.3390/ijms12021060Zhang, Cui, Li, Wang, Yu et al., Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization, Commun Biol,
doi:10.1038/s42003-021-02728-4Zhang, Hamdoun, Chen, Yang, Ip et al., Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with biolayer interferometry, Pharmacol Res,
doi:10.1016/j.phrs.2021.105820Zhang, Rao, Li, Zhu, Liu et al., High dose vitamin C infusion for the treatment of critically ill COVID-19, Ann Intensive Care,
doi:10.1186/s13613-020-00792-3
